Sign in
4

Changes in Ownership

IGC Pharma, Inc. Filed Acc 0001185185-26-002765

CEO acquired 2,226,475 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mukunda Ram · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-30 Grant or award : show line 1 in the form +2,226,475 $0.27 $601,148 6,875,563 D
Loading xslF345X06/ownership.xml…